HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Crestline Management LP

Crestline Management LP raised its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 414.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,117 shares of the company's stock after buying an additional 3,317 shares during the quarter. Crestline Management LP's holdings in HCA Healthcare were worth $1,236,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Whipplewood Advisors LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter worth $31,000. Tidemark LLC bought a new stake in shares of HCA Healthcare during the 4th quarter worth $36,000. Activest Wealth Management raised its position in HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after purchasing an additional 125 shares in the last quarter. Pinnacle Bancorp Inc. increased its position in shares of HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. Finally, Legacy Investment Solutions LLC boosted its stake in HCA Healthcare by 99.0% in the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after buying an additional 95 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Barclays decreased their price objective on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. Robert W. Baird reissued a "neutral" rating and set a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Royal Bank of Canada reduced their price objective on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Cantor Fitzgerald reiterated an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. Finally, Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $381.13.

HCA Healthcare Trading Up 2.6%

NYSE HCA traded up $9.28 on Monday, hitting $362.98. 1,679,352 shares of the stock were exchanged, compared to its average volume of 1,406,961. The stock has a fifty day moving average price of $335.93 and a two-hundred day moving average price of $327.81. The firm has a market capitalization of $87.32 billion, a P/E ratio of 16.52, a P/E/G ratio of 1.10 and a beta of 1.46. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The firm had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. During the same period in the prior year, the business posted $5.36 earnings per share. The company's revenue for the quarter was up 5.7% on a year-over-year basis. Research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.79%. HCA Healthcare's payout ratio is currently 12.81%.

Insiders Place Their Bets

In other news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.